These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 28447399)
1. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. Jia P; Zhao Z; Hulgan T; Bush WS; Samuels DC; Bloss CS; Heaton RK; Ellis RJ; Schork N; Marra CM; Collier AC; Clifford DB; Gelman BB; Sacktor N; Morgello S; Simpson DM; McCutchan JA; Barnholtz-Sloan JS; Franklin DR; Rosario D; Letendre SL; Grant I; Kallianpur AR; Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):413-426. PubMed ID: 28447399 [TBL] [Abstract][Full Text] [Related]
2. Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection. Hulgan T; Kallianpur AR; Guo Y; Barnholtz-Sloan JS; Gittleman H; Brown TT; Ellis R; Letendre S; Heaton RK; Samuels DC; J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e95-e102. PubMed ID: 30531306 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection. Hulgan T; Samuels DC; Bush W; Ellis RJ; Letendre SL; Heaton RK; Franklin DR; Straub P; Murdock DG; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I; Kallianpur AR; Clin Infect Dis; 2015 Nov; 61(9):1476-84. PubMed ID: 26129753 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults. Levine AJ; Service S; Miller EN; Reynolds SM; Singer EJ; Shapshak P; Martin EM; Sacktor N; Becker JT; Jacobson LP; Thompson P; Freimer N Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):669-83. PubMed ID: 22628157 [TBL] [Abstract][Full Text] [Related]
5. Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities. Campbell LM; Fennema-Notestine C; Saloner R; Hussain M; Chen A; Franklin D; Umlauf A; Ellis RJ; Collier AC; Marra CM; Clifford DB; Gelman BB; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Heaton RK; J Int Neuropsychol Soc; 2020 Feb; 26(2):147-162. PubMed ID: 31576785 [TBL] [Abstract][Full Text] [Related]
6. Genetic Variations in EIF2AK3 are Associated with Neurocognitive Impairment in People Living with HIV. Akay-Espinoza C; Newton SEB; Dombroski BA; Kallianpur A; Bharti A; Franklin DR; Schellenberg GD; Heaton RK; Grant I; Ellis RJ; Letendre SL; Jordan-Sciutto KL J Neuroimmune Pharmacol; 2024 May; 19(1):25. PubMed ID: 38789639 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. Morgan EE; Woods SP; Letendre SL; Franklin DR; Bloss C; Goate A; Heaton RK; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Ellis RJ; Abramson I; Gamst A; Fennema-Notestine C; Smith DM; Grant I; Vaida F; Clifford DB; J Neurovirol; 2013 Apr; 19(2):150-6. PubMed ID: 23408335 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. Mehta SR; Pérez-Santiago J; Hulgan T; Day TR; Barnholtz-Sloan J; Gittleman H; Letendre S; Ellis R; Heaton R; Patton S; Suben JD; Franklin D; Rosario D; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur J; McCutchan A; Morgello S; Simpson D; Connor J; Grant I; Kallianpur A J Neuroinflammation; 2017 Mar; 14(1):72. PubMed ID: 28359324 [TBL] [Abstract][Full Text] [Related]
9. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool. Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection. Kallianpur AR; Gittleman H; Letendre S; Ellis R; Barnholtz-Sloan JS; Bush WS; Heaton R; Samuels DC; Franklin DR; Rosario-Cookson D; Clifford DB; Collier AC; Gelman B; Marra CM; McArthur JC; McCutchan JA; Morgello S; Grant I; Simpson D; Connor JR; Hulgan T; Mol Neurobiol; 2019 May; 56(5):3808-3818. PubMed ID: 30209774 [TBL] [Abstract][Full Text] [Related]
13. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530 [TBL] [Abstract][Full Text] [Related]
14. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I; J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344 [TBL] [Abstract][Full Text] [Related]
15. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection. Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875 [TBL] [Abstract][Full Text] [Related]
16. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. McCutchan JA; Marquie-Beck JA; Fitzsimons CA; Letendre SL; Ellis RJ; Heaton RK; Wolfson T; Rosario D; Alexander TJ; Marra C; Ances BM; Grant I; Neurology; 2012 Feb; 78(7):485-92. PubMed ID: 22330412 [TBL] [Abstract][Full Text] [Related]
17. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland. Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M; Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882 [TBL] [Abstract][Full Text] [Related]
18. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder. Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278 [TBL] [Abstract][Full Text] [Related]
19. Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment. Underwood J; De Francesco D; Leech R; Sabin CA; Winston A; PLoS One; 2018; 13(4):e0194760. PubMed ID: 29641619 [TBL] [Abstract][Full Text] [Related]